Rotigotine Effect on Nocturnal Hypokinesia Compares to Placebo Control: A Quantitative Assessment by Wearable Sensors
Latest Information Update: 12 Feb 2019
At a glance
- Drugs Rotigotine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 08 Jun 2017 Primary endpoint (Nocturnal parameters from wearable sensors during nighttime) has been met, according to the results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
- 08 Jun 2017 Results presented at the 21st International Congress of Parkinson's Disease and Movement Disorders
- 03 Apr 2017 New trial record